Found: 127
Select item for more details and to access through your institution.
The Inflation Reduction Act: Implications for Medicare spending and access to biologic therapies for chronic rhinosinusitis with nasal polyposis and asthma.
- Published in:
- International Forum of Allergy & Rhinology, 2024, v. 14, n. 7, p. 1261, doi. 10.1002/alr.23344
- By:
- Publication type:
- Article
Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. 527, doi. 10.1093/oncolo/oyae035
- By:
- Publication type:
- Article
Consuming Patients' Days: Time Spent on Ambulatory Appointments by People With Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 400, doi. 10.1093/oncolo/oyae016
- By:
- Publication type:
- Article
Medicare Part D Payments for Generic Imatinib From 2017 to 2023.
- Published in:
- JAMA Internal Medicine, 2024, v. 184, n. 1, p. 104, doi. 10.1001/jamainternmed.2023.3932
- By:
- Publication type:
- Article
Aiming at the Right Targets on Drug Price Reform.
- Published in:
- Journal of Law, Medicine & Ethics, 2023, v. 51, p. 55, doi. 10.1017/jme.2023.160
- By:
- Publication type:
- Article
Quality of Medication Cost Conversations and Interest in Future Cost Conversations Among Older Adults.
- Published in:
- JGIM: Journal of General Internal Medicine, 2023, v. 38, n. 16, p. 3482, doi. 10.1007/s11606-023-08388-w
- By:
- Publication type:
- Article
Cost-Related Barriers and Ensuring Equitable Access to Vaccines in the US.
- Published in:
- 2023
- By:
- Publication type:
- Opinion
Trends in U.S. self-reported health and self-care behaviors during the COVID-19 pandemic.
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0291667
- By:
- Publication type:
- Article
Commercial Health Plan and Enrollee Out-of-Pocket Spending on Accelerated Approval Products in 2019.
- Published in:
- JAMA Internal Medicine, 2023, v. 183, n. 9, p. 1016, doi. 10.1001/jamainternmed.2023.2381
- By:
- Publication type:
- Article
Buprenorphine Out-of-Pocket Costs and Discontinuation in Privately Insured Adults With Opioid Use Disorder.
- Published in:
- JAMA Internal Medicine, 2023, v. 183, n. 9, p. 1023, doi. 10.1001/jamainternmed.2023.2826
- By:
- Publication type:
- Article
Trends in the Use of Mifepristone for Medical Management of Early Pregnancy Loss From 2016 to 2020.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 8, p. 766, doi. 10.1001/jama.2023.13628
- By:
- Publication type:
- Article
Utilization Management Trends in Medicare Part D Oncology Drugs, 2010-2020.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 3, p. 278, doi. 10.1001/jama.2023.10753
- By:
- Publication type:
- Article
Health Insurer Strategies to Reduce Specialty Drug Spending—Copayment Adjustment and Alternative Funding Programs.
- Published in:
- 2023
- By:
- Publication type:
- Opinion
Time to Confirmatory Study Initiation After Accelerated Approval of Cancer and Noncancer Drugs in the US.
- Published in:
- JAMA Internal Medicine, 2023, v. 183, n. 7, p. 737, doi. 10.1001/jamainternmed.2023.0777
- By:
- Publication type:
- Article
High Deductible Health Plans and Use of Free Preventive Services Under the Affordable Care Act.
- Published in:
- Inquiry (00469580), 2023, p. 1, doi. 10.1177/00469580231182512
- By:
- Publication type:
- Article
The Inflation Reduction Act: How Will Medicare Negotiating Drug Prices Impact Patients with Heart Disease?
- Published in:
- Current Cardiology Reports, 2023, v. 25, n. 6, p. 577, doi. 10.1007/s11886-023-01878-7
- By:
- Publication type:
- Article
Examining Opportunities to Increase Savings From Medicare Price Negotiations.
- Published in:
- JAMA Internal Medicine, 2023, v. 183, n. 6, p. 581, doi. 10.1001/jamainternmed.2023.0763
- By:
- Publication type:
- Article
Cost-Related Medication Nonadherence and Desire for Medication Cost Information Among Adults Aged 65 Years and Older in the US in 2022.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 5, p. e2314211, doi. 10.1001/jamanetworkopen.2023.14211
- By:
- Publication type:
- Article
Association Between Low-Income Subsidies and Inequities in Orally Administered Antimyeloma Therapy Use.
- Published in:
- American Journal of Managed Care, 2023, v. 29, n. 5, p. 246, doi. 10.37765/ajmc.2023.89357
- By:
- Publication type:
- Article
"Worth it if you could afford it": Patient perspectives on integrating real‐time benefit tools into drug cost conversations.
- Published in:
- Journal of the American Geriatrics Society, 2023, v. 71, n. 5, p. 1627, doi. 10.1111/jgs.18226
- By:
- Publication type:
- Article
Stemming Medicare Spending on Discarded Drugs—Waste Not, Want Not?
- Published in:
- 2023
- By:
- Publication type:
- Opinion
Demand for and Occurrence of Medication Cost Conversations: A Narrative Review.
- Published in:
- Medical Care Research & Review, 2023, v. 80, n. 1, p. 16, doi. 10.1177/10775587221108042
- By:
- Publication type:
- Article
Gender-Affirming Hormone Therapy Spending and Use in the USA, 2013–2019.
- Published in:
- JGIM: Journal of General Internal Medicine, 2023, v. 38, n. 1, p. 260, doi. 10.1007/s11606-022-07693-0
- By:
- Publication type:
- Article
The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 1, p. 1, doi. 10.1007/s00520-022-07472-x
- By:
- Publication type:
- Article
Cost-Sharing Reform for Chronic Disease Treatments as a Strategy to Improve Health Care Equity and Value in the US.
- Published in:
- 2022
- By:
- Publication type:
- Opinion
Premiums and Out-of-Pocket Spending for Long-acting Insulins Under the Medicare Part D Senior Savings Model.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 328, n. 21, p. 2161, doi. 10.1001/jama.2022.17232
- By:
- Publication type:
- Article
The Price of Progress: Managing Prescription Drug Spending.
- Published in:
- Journal of Health Politics, Policy & Law, 2022, v. 47, n. 6, p. 621, doi. 10.1215/03616878-10041065
- By:
- Publication type:
- Article
Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits.
- Published in:
- Journal of Health Politics, Policy & Law, 2022, v. 47, n. 6, p. 673, doi. 10.1215/03616878-10041107
- By:
- Publication type:
- Article
Reforming Reimbursement for the US Food and Drug Administration's Accelerated Approval Program to Support State Medicaid Programs.
- Published in:
- JAMA Health Forum, 2022, v. 3, n. 11, p. e224115, doi. 10.1001/jamahealthforum.2022.4115
- By:
- Publication type:
- Article
Out-of-pocket Cost Burden Associated With Contemporary Management of Advanced Prostate Cancer Among Commercially Insured Patients.
- Published in:
- AUANews, 2022, v. 27, p. 13
- By:
- Publication type:
- Article
Real-time Prescription Benefit Tools-The Promise and Peril.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Price Comparison of Human and Veterinary Formulations of Common Medications.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prescription Drug Spending in Fee-for-Service Medicare, 2008-2019.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 328, n. 15, p. 1515, doi. 10.1001/jama.2022.17825
- By:
- Publication type:
- Article
Out‐of‐pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population.
- Published in:
- International Forum of Allergy & Rhinology, 2022, v. 12, n. 10, p. 1295, doi. 10.1002/alr.22976
- By:
- Publication type:
- Article
Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. e2231475, doi. 10.1001/jamanetworkopen.2022.31475
- By:
- Publication type:
- Article
Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. e2233006, doi. 10.1001/jamanetworkopen.2022.33006
- By:
- Publication type:
- Article
What Should I Know About Coverage With Medicare Part D?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Intermediate Strengths and Inflated Prices: The Story of Transdermal Fentanyl Patches.
- Published in:
- Journal of Palliative Medicine, 2022, v. 25, n. 9, p. 1335, doi. 10.1089/jpm.2022.0241
- By:
- Publication type:
- Article
Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 7, p. e2221468, doi. 10.1001/jamanetworkopen.2022.21468
- By:
- Publication type:
- Article
Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. e2215720, doi. 10.1001/jamanetworkopen.2022.15720
- By:
- Publication type:
- Article
Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. 1, doi. 10.1001/jamanetworkopen.2022.15720
- By:
- Publication type:
- Article
Reducing Health Disparities Through Achieving Pharmacoequity—Reply.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Persistent Prescription Drug Affordability Challenges for Medicare Beneficiaries With Multiple Chronic Conditions-What Goes Up Must Come Down?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Changes in the Use of Hydroxyprogesterone Caproate Injection After Confirmatory Trial Failure.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 12, p. e2137390, doi. 10.1001/jamanetworkopen.2021.37390
- By:
- Publication type:
- Article
Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Policy Prescription for Reducing Health Disparities-Achieving Pharmacoequity.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 326, n. 18, p. 1793, doi. 10.1001/jama.2021.17764
- By:
- Publication type:
- Article
Evaluating the Contribution of Patient-Provider Communication and Cancer Diagnosis to Racial Disparities in End-of-Life Care Among Medicare Beneficiaries.
- Published in:
- JGIM: Journal of General Internal Medicine, 2021, v. 36, n. 11, p. 3311, doi. 10.1007/s11606-021-06778-6
- By:
- Publication type:
- Article
Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval.
- Published in:
- JAMA Health Forum, 2021, v. 2, n. 10, p. 1, doi. 10.1001/jamahealthforum.2021.3177
- By:
- Publication type:
- Article